Article
Glitazones, PPAR-γ and Neuroprotection
4 Mar 2021
Abstract excerpt
The transcriptional factor PPAR-γ belongs to the nuclear receptor family, which has become a potential therapeutic target for several neurodegenerative diseases and metabolic disorders. Interestingly, PPAR-γ has been reported to have beneficial effects in various chronic neurological conditions via upregulation of its transcriptional co-activator PGC-1α and followed by regulation of multiple molecular events....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
